EWA
MBOT icon

EverSource Wealth Advisors’s Microbot Medical MBOT Stock Holding History

EverSource Wealth Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696 Hold
357
– – ﹤0.01% 4065
2026
Q1 		$860 Hold
357
– – ﹤0.01% 3905
2025
Q4 		$714 Hold
357
– – ﹤0.01% 3792
2025
Q3 		$1.09K Hold
357
– – ﹤0.01% 3738
2025
Q2 		$900 Hold
357
– – ﹤0.01% 3763
2025
Q1 		$539 Buy
+357
New +$631 ﹤0.01% 3433

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

EverSource Wealth Advisors's MBOT Position: Q2 2026 in Review

EverSource Wealth Advisors held its Microbot Medical (MBOT) position steady in Q2 2026 at 357 shares worth $696. The position accounts for ﹤0.01% of the portfolio, ranked #4065.

EverSource Wealth Advisors first reported a position in MBOT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.09K in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • EverSource Wealth Advisors held 357 shares of Microbot Medical worth $696 as of Q2 2026.
  • EverSource Wealth Advisors left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4065 holding.
  • EverSource Wealth Advisors first reported a position in Microbot Medical in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Microbot Medical position peaked at $1.09K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.